ATS Medical Participating in 44th Annual STS Annu...( MINNEAPOLIS Jan. 24 /- ATS Medica...),Health

MINNEAPOLIS, Jan. 24 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ATSI) is looking forward to its participation in the 44th Annual Meeting of the Society of Thoracic Surgeons (STS). The event runs January 28-30, 2008 in Fort Lauderdale, Florida, and serves as one of the year's key gatherings of cardiovascular surgeons from around the world.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040202/ATSILOGO)

ATS Medical continues to broaden its exposure and relationships within the cardiac surgery community and the STS meeting provides an excellent opportunity to display the progress made in assembling an array of product offerings focused on meeting the evolving needs of cardiac surgeons. Featured products will include the company's flagship ATS Open Pivot(R) Heart Valve and our latest advancement, the ATS Open Pivot(R) AP360(TM). Recently approved in the US, the AP360 expands upon the fundamental strengths of the open pivot design by maximizing hemodynamic performance while incorporating a cuff design that will extend the valve's appeal to a broader spectrum of surgeon preferences.

ATS 3f(R) tissue heart valve products will be prominently featured. In-booth presentations on Monday, January 28th will include Dr. Richard Shemin, UCLA Medical Center, presenting a "Review of FDA Clinical Data with the ATS 3f(R) Aortic Bioprosthesis" and Professor Thierry Carrel, University Hospital of Berne, reporting on "Experience with the Sutureless ATS 3f Enable(TM) Aortic Bioprosthesis".

The ATS Simulus(R) annuloplasty product family, designed for the heart valve repair market segment, has expanded with the recent FDA approval of the ATS Simul
'/>"/>